Bristol-myers Squibb Drug Patent Portfolio

Bristol-myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol-myers Squibb News

Is Bristol-Myers Squibb's (US0897961004) leadership in oncology robust?

20 Apr, 2026

Bristol-Myers Squibb's stock: Does its cancer treatment pipeline have the potential to drive growth?

20 Apr, 2026

Is the oncology pipeline robust for Bristol-Myers Squibb Company (US0897961004)?

17 Apr, 2026

The significance of Bristol-Myers Squibb Company's (US0897961004) leadership in oncology.

14 Apr, 2026

See More